Although its function through TNFR1 effectively favors the death of cancer cells while promoting the T cell pro-inflammatory response via NF-κB signaling, the activation of TNFR2 on immunosuppressive cells recruited by the tumor could be detrimental for anti-cancer responses. This evidence concerns the gene NFKB1 and neoplasm.